NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000788

Registered date:01/04/2012

A clinical trial of liver SPIO-MRI in the diagnosis of nonalcoholic steatohepatitis

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedNonalcoholic steatohepatitis
Date of first enrollment2006/01/01
Target sample size20
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Duration: three years Patients, who will undergo liver biopsy for clinical suspicion of nonalcoholic steatohepatitis (NASH), will be enrolled in this study. The patients will take liver SPIO-MRI examination at the time of liver biopsy. The aim of this study is to identify the liver SPIO-MRI findings in patients with biopsy-proven "NASH" and "not NASH", and to assess their correlations with the clinicopathological variables.

Outcome(s)

Primary OutcomeLiver imaging in SPIO-MRI
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteriaThe patients who have no normal judgement ability for infomed consent. The patients who have past history of allergy to Resovist, contrast agent for liver SPIO-MRI, or kind medicine. The patients who are pregnant or will doublfully be pregnant. The patients who the treating doctors decide are inadequate to enrollment to this trial.

Related Information

Contact

public contact
Name Kengo Tomita
Address 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan Japan
Telephone 03-3353-1211(ext62384)
E-mail kengo@boreas.dti.ne.jp
Affiliation Department of Internal Medicine, Keio University School of Medicine Division of Gastroenterolgy and Hepatology
scientific contact
Name Kengo Tomita
Address 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan Japan
Telephone 03-3353-1211(ext62384)
E-mail
Affiliation Department of Internal Medicine, Keio University School of Medicine Division of Gastroenterology and Hepatology